Market Tracker

02/11 5:16pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

34.12
Delayed Data
As of Feb 11
 -0.51 / -1.47%
Today’s Change
30.30
Today|||52-Week Range
46.24
-20.95%
Year-to-Date

Today’s Trading

Previous close34.63
Today’s open34.08
Day’s range33.89 - 34.57
Volume1,060,588
Average volume (3 months)941,806
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.96%
Earnings growth (next 5 years)+15.70%
Revenue growth (last year)-7.08%
P/E ratio25.7
Price/Sales3.50
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.16-0.98%
ICPTIntercept Pharmaceut...-1.45-1.51%
IPXLImpax Laboratories I...-1.45-4.51%
AKRXAkorn Inc-1.57-6.48%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts